Evidence map›Paper›PMID 34804053›Full record

ArticleFrontiers in immunology2021

Respiratory and Intramuscular Immunization With ChAdOx2-NPM1-NA Induces Distinct Immune Responses in H1N1pdm09 Pre-Exposed Pigs.

Eleni Vatzia, Elizabeth R Allen, Tanuja Manjegowda, Susan Morris, Adam McNee, Veronica Martini, Reshma Kaliath, Marta Ulaszewska, Amy Boyd, Basudev Paudyal and 9 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Lung B cells in ectopic germinal centers undergo affinity maturation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. SARS-CoV-2-Specific CD8Vaccines · 2023
    Article
  7. Article
  8. Animal models for COVID-19 and tuberculosis.Frontiers in immunology · 2023
    Review
  9. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease?International journal of molecular sciences · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Eleni VatziaEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Elizabeth R AllenNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Tanuja ManjegowdaEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Susan MorrisNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Adam McNeeEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Veronica MartiniEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Reshma KaliathNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Marta UlaszewskaNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Amy BoydNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Basudev PaudyalEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Veronica B CarrEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Tiphany ChrunEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Emmanuel MazeEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
Ronan MacLoughlinAerogen Ltd., Galway, Ireland.
Pauline M van DiemenAnimal and Plant Health Agency (APHA)-Weybridge, Addlestone, United Kingdom.
Helen E EverettAnimal and Plant Health Agency (APHA)-Weybridge, Addlestone, United Kingdom.
Teresa LambeNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Sarah C GilbertNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Elma TchilianEnhanced Host Responses, The Pirbright Institute, Pirbright, United Kingdom.
The Pirbright Institute · GBUniversity of Oxford · GBJenner Institute · GBAnimal and Plant Health Agency · GBAerogen (Ireland) · IE

Funding

Biotechnology and Biological Sciences Research Council BB/S506680/1Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007037Biotechnology and Biological Sciences Research Council BBS/E/I/00007039Medical Research Council MR/S037160/1
6 · The paper itself

Abstract

There is a critical need to develop superior influenza vaccines that provide broader protection. Influenza vaccines are traditionally tested in naive animals, although humans are exposed to influenza in the first years of their lives, but the impact of prior influenza exposure on vaccine immune responses has not been well studied. Pigs are an important natural host for influenza, are a source of pandemic viruses, and are an excellent model for human influenza. Here, we investigated the immunogenicity of the ChAdOx2 viral vectored vaccine, expressing influenza nucleoprotein, matrix protein 1, and neuraminidase in H1N1pdm09 pre-exposed pigs. We evaluated the importance of the route of administration by comparing intranasal, aerosol, and intramuscular immunizations. Aerosol delivery boosted the local lung T-cell and antibody responses, while intramuscular immunization boosted peripheral blood immunity. These results will inform how best to deliver vaccines in order to harness optimal protective immunity.

Indexed as

AdenoviridaeAerosolsAnimalsAntibodies, ViralCytokinesInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesNeuraminidaseNucleocapsid ProteinsSwineVaccinationViral Matrix ProteinsVirus SheddingAerosolsAntibodies, ViralCytokinesInfluenza VaccinesM1 protein, Influenza A virusNeuraminidaseNucleocapsid ProteinsViral Matrix Proteinsaerosolinfluenza AintramuscularintranasalpdmH1N1pigpre-exposurevaccine

Identifiers

PMID34804053
PMCPMC8595216
OpenAlexW3189833965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.